Announcement on Abnormal Stock Trading Fluctuations

Wanbang Pharmaceutical Co., Ltd.·August 11, 2026·2 pages

✨ AI Summary

Anbang Pharmaceutical Technology Co., Ltd. announces abnormal stock trading fluctuations, with a cumulative increase exceeding 30% over three trading days. The company has conducted self-inspections and confirmed no undisclosed material information, no violations of fair disclosure, and no trading by controlling shareholders. The company will release its interim report on August 29, 2026.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Stock Code: 301520

Stock Abbreviation: Wanbang Medicine

Announcement No.: 2026-027

Anbang Pharmaceutical Technology Co., Ltd.

Announcement on Abnormal Stock Trading Fluctuations

The Company and the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and contains no false records, misleading statements, or major omissions.

I. Explanation of Abnormal Stock Trading Fluctuations

The stock trading price of Anbang Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "the Company") (Stock Abbreviation: Wanbang Medicine, Stock Code: 301520) has deviated from the daily closing price by more than 30% cumulatively over three consecutive trading days (August 7, 2026, August 10, 2026, and August 11, 2026). In accordance with the "Trading Rules of Shenzhen Stock Exchange" and other relevant regulations, this constitutes abnormal stock trading fluctuations.

II. Company's Attention and Verification

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.